RDP Pharma

RDP Pharma AG is a Swiss biotechnology company dedicated to developing a new generation of targeted protein degraders for the treatment of diseases with unmet medical needs. Its proprietary PromptDegrader™ platform enables the development of highly selective monovalent degrader molecules targeting challenging indications such as cancer, inflammation, and neurodegenerative diseases.